XML 111 R88.htm IDEA: XBRL DOCUMENT v3.25.0.1
Share capital - Equity-Based Compensation Expenses Related to Company's Equity-Based Awards (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Total share-based compensation expense $ 160,035 $ 115,608 $ 106,955
Cost of revenues      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Total share-based compensation expense 6,873 6,587 4,690
Research, development and clinical studies      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Total share-based compensation expense 32,716 31,827 30,790
Sales and marketing      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Total share-based compensation expense 43,097 35,968 28,826
General and administrative      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Total share-based compensation expense $ 77,349 $ 41,226 $ 42,649